We are live on ! Find out more
ORIC icon

Oric Pharmaceuticals
ORIC

66 hedge funds and large institutions have $722M invested in Oric Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 66 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

71.95% more ownership

Funds ownership: 0% → 71.95% (+72%)

Holders
66
Holders Change
+66
Holders Change %
–
% of All Funds
1.35%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.1%
New
66
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
PS
Peter Svennilson
+$152M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$134M
3
O
OrbiMed
New York
+$93.3M
4
EC
EcoR1 Capital
California
+$84.3M
5
IFA
Invus Financial Advisors
New York
+$32.2M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
26
Suvretta Capital Management
New York
$2.58M +$2.44M +76,432 New
Charles Schwab
27
Charles Schwab
California
$1.81M +$1.71M +53,722 New
N
28
Nuveen
North Carolina
$1.14M +$1.08M +33,693 New
RJA
29
Raymond James & Associates
Florida
$1.02M +$967K +30,285 New
PPA
30
Parametric Portfolio Associates
Washington
$791K +$748K +23,438 New
Bank of New York Mellon
31
Bank of New York Mellon
New York
$766K +$725K +22,706 New
SG Americas Securities
32
SG Americas Securities
New York
$758K +$717K +22,477 New
California Public Employees Retirement System
33
California Public Employees Retirement System
California
$649K +$614K +19,249 New
Jane Street
34
Jane Street
New York
$646K +$612K +19,161 New
SI
35
Sofinnova Investments
California
$585K +$554K +17,369 New
State of Wisconsin Investment Board
36
State of Wisconsin Investment Board
Wisconsin
$469K +$444K +13,900 New
Bank of America
37
Bank of America
North Carolina
$451K +$426K +13,360 New
California State Teachers Retirement System (CalSTRS)
38
California State Teachers Retirement System (CalSTRS)
California
$443K +$419K +13,129 New
UBS AM
39
UBS AM
Illinois
$431K +$408K +12,775 New
CCM
40
CAAS Capital Management
New York
$422K +$399K +12,500 New
Norges Bank
41
Norges Bank
Norway
$422K +$399K +12,500 New
Ameriprise
42
Ameriprise
Minnesota
$371K +$351K +10,998 New
CSS
43
Cubist Systematic Strategies
Connecticut
$357K +$338K +10,598 New
ZP
44
Zimmer Partners
New York
$354K +$335K +10,500 New
Goldman Sachs
45
Goldman Sachs
New York
$346K +$328K +10,264 New
AllianceBernstein
46
AllianceBernstein
Tennessee
$344K +$326K +10,200 New
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$341K +$323K +10,109 New
New York State Common Retirement Fund
48
New York State Common Retirement Fund
New York
$270K +$255K +8,000 New
PCM
49
Pentwater Capital Management
Florida
$270K +$255K +8,000 New
Citadel Advisors
50
Citadel Advisors
Florida
$230K +$218K +6,831 New
1
2
3

ORIC Hedge Fund Activity: Q2 2020 in Review

66 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Oric Pharmaceuticals (ORIC) for Q2 2020, worth a combined $722M.

Buyers outnumbered sellers: 66 funds opened new ORIC positions and 0 closed out — a net gain of 66 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Peter Svennilson, opening a new position worth an estimated $152M.

  • 66 institutional investors held Oric Pharmaceuticals (ORIC) as of Q2 2020, up from 0 in Q1 2020.
  • Funds reported $722M of Oric Pharmaceuticals stock for Q2 2020.
  • 66 funds opened new Oric Pharmaceuticals positions in Q2 2020 and 0 closed out, a net change of +66 holders.
  • The largest Oric Pharmaceuticals buyer in Q2 2020 was Peter Svennilson, an estimated $152M added.

Based on aggregated 13F filings for Q2 2020.